Equity Risk Sciences Announces $20 Million Capital Raise and National Expansion Plan

, /PRNewswire/ — Equity Risk Sciences (ERS), the nation’s only independent stock risk rating agency, today announced a $20 million capital raise at $10.00 per share to fuel a national communications campaign highlighting investors’ #1 need: to reduce, prevent and avoid losses.

12 years ago today, Raymond Mullaney, founder of ERS, hired Tom Harpin, an exceptional mathematician and data scientist. Mullaney’s goal: Transform investing by utilizing the most advanced technology, data science and AI, making it safer, smarter, and more rewarding. See Investor Handout at www.ERS.ai, outlining 15 compelling reasons to join ERS’s revolutionary investment opportunity.

“We’ve engineered proprietary risk ratings which, when used, will substantially reduce investor losses,” declared Mullaney.

Disrupting a $100 Trillion Industry with Proven Science

ERS addresses the most critical question investors rarely ask: “What’s the risk?” The company’s proprietary ratings consistently identify companies destined for catastrophic losses while highlighting those positioned for sustainable returns—validated by a decade of rigorous testing across all market periods in the past 25 years.

This capital raise will accelerate three strategic initiatives:

National Investment Risk Awareness Campaign: A comprehensive education initiative led by respected leaders across the political spectrum, rallying investors around the core principle: “Know the Risks Before You Invest.”
Premium Institutional Products: Launch of the exclusive Fiduciary Approved Stock List™—a high-margin subscription service available to select institutions. Those approved will earn the exclusive right to advertise their use of ERS’s trusted list—a premium branding advantage, and a powerful new revenue stream for subscribers and ERS.
Launch of InvestLabs.ai Platform: Funding will also support the development and rollout of InvestLabs.ai, ERS’s institutional-grade platform for risk analytics, portfolio design and testing, and advanced investment research. InvestLabs.ai will provide subscribers with access to ERS’s powerful suite of tools—including the Profit Map™, Portfolio Risk Analyzer™, Present Screener™, Multi Portfolio Screener™, Active Risk Monitoring™, Decision Metrics™ and Stock Prognosis™, to name a few—and the ability to design, build, test, and refine their own proprietary portfolio strategies.

The platform’s built-in research lab will allow analysts to test the predictive power of over 100 different financial metrics, helping them identify which metrics reliably improve performance and reduce risk. Whether building model portfolios, back-testing strategies, or designing proprietary ratings, InvestLabs.ai gives investment professionals a profound edge—combining ERS’s proven data science with flexible, advisor-driven innovation.

Powered by Purpose, Proven by Data, Driven by Results

ERS’s technology has undergone exhaustive testing against decades of market data, consistently demonstrating superior accuracy in identifying both high-risk investments and stable, profitable opportunities. This proven track record positions ERS to capture significant market share in the growing risk management sector.

The company’s business model generates revenue through multiple streams: institutional subscriptions, fiduciary tools licensing, and premium advisory services—creating a sustainable, scalable platform for long-term growth.

ERS has rigorously honed its technology using 35+ years of data from 15,000+ public companies. The verdict? Our risk ratings pinpoint catastrophe-prone stocks with precision—and spotlight those primed for robust, enduring gains.

About ERS

Equity Risk Sciences is America’s only fully independent stock risk rating agency, using advanced technology and AI to create ratings that reliably forecast the probability, scale, and timing of stock price movements. ERS’s ratings help fiduciaries and financial institutions avoid, prevent and reduce losses and capture gains on stocks suitable for fiduciaries, making investing safer and more rewarding.

ERS doesn’t sell stocks. We built Risk Ratings to Protect Capital™.

Contact Francesca Okleasky, communications manager, at (203) 254-0000 or [email protected] to arrange a call or meeting with Mr. Mullaney.

For the complete Investor Handout detailing 15 compelling reasons to invest in ERS, visit: www.ERS.ai

SOURCE Equity Risk Sciences, Inc.